IMPORTANT: Read the Prep & Injection Guide for proper reconstitution, syringe sizing, and injection protocols. Mistakes here can compromise your research.
The GLOW blend is a three-peptide combination aimed at reducing visible signs of aging by improving skin and hair health, and — thanks to its tissue-regenerating components — supporting wound healing and the reduction of scar tissue. Each 70 mg vial contains:
- BPC-157 – 10 mg: Stimulates collagen synthesis, reduces scar tissue, and accelerates wound healing across skin, muscle, tendon, ligament, and other tissues.
- GHK-Cu – 50 mg: Stimulates elastin and collagen production, improves skin hydration and elasticity, reduces fine lines, photodamage, and hyperpigmentation, protects against UV and free-radical damage, and accelerates hair growth (studied as equal to or better than Minoxidil 5%) while enlarging and strengthening hair follicles.
- TB-500 – 10 mg: Promotes collagen production, reduces scarring, and protects, regenerates, and remodels injured tissue — wounds treated with TB-500 show more mature, tightly organized collagen structures. Also stimulates and strengthens hair follicles for faster, thicker growth.
— 70 mg Blend Vial —
Reconstitute: Add 2.5 mL (250 units) bacteriostatic water.
Administration: Subcutaneous injection.
Timing: May be dosed at any time of day; fasting is not necessary.
Storage: Refrigerate at 2–8 °C after reconstitution.
Schedule: Once daily, 7 days per week.
Cycle Length: 6–12 weeks on, followed by a 6–12 week washout period.
Goal: Skin rejuvenation, hair regrowth/strengthening, wound healing, and scar reduction.
Standard Protocol
| Phase | Dose | Syringe (U-100) |
|---|---|---|
| Entire cycle (6–12 weeks) | 1–2 mg GHK-Cu equivalent, once daily | 5–10 units (0.05–0.10 mL) |
Injection tips (GHK-Cu can sting at the injection site): After drawing your dose, dilute it with 20 or more units of bacteriostatic water or sterile injection solution; gently massage the site for about 60 seconds after injecting to aid absorption; and rotate injection sites daily for comfort.
- Improves skin health and appearance; reduces fine lines, wrinkles, photodamage, and hyperpigmentation.
- Restores skin elasticity and helps reverse the thinning of aging skin; improves hydration.
- Stimulates collagen and elastin synthesis across all three components.
- Accelerates hair growth; enlarges, strengthens, and thickens hair follicles; supports hair regrowth.
- Accelerates wound healing in skin, muscle, tendon, ligament, and other tissues.
- Reduces scar tissue and promotes tightly organized collagen structures in healing wounds.
- Anti-inflammatory and antioxidant activity; reduces free-radical damage and protects against UV exposure.
- Boosts antibody production (TB-500 component).
While side effects are not common, you may experience:
- Injection site reactions (redness, swelling, itching, tenderness, lumps and/or bruising)
- Allergic reaction (rare) — signs include swelling and difficulty breathing
For some users, GHK-Cu (a copper peptide) is painful to inject and/or may cause a reaction at the injection site — ranging from a small pinch to a strong sting, with possible redness, swelling, bruising, pain, or a knot beneath the skin lasting several days. Others experience neither. Individuals more sensitive to copper ions tend to have:
- Low baseline ceruloplasmin (the copper-binding protein that regulates free copper)
- An already-inflamed skin barrier or microcirculation
- Trace metal imbalances (e.g., low zinc or high iron)
When injected, free copper can temporarily separate from GHK, generating mild oxidative activity and histamine release in the area. To prevent or minimize reactions: (1) always rotate injection sites — never use the same spot twice in a row; (2) after drawing your daily dose, add 30–90 units of water to the shot to dilute the GHK-Cu; (3) note that when GHK-Cu and BPC-157 are combined (as in GLOW), injection pain decreases substantially versus GHK-Cu alone.
If injections remain intolerable even after dilution, the remaining reconstituted solution can be mixed into a half-ounce to an ounce of a thick moisturizing cream or ointment and applied topically beneath a secondary moisturizer.
- Do not use when pregnant or nursing.
- Use caution with active cancer — regenerative peptides in this blend promote angiogenesis and cell migration.
- Known copper sensitivity: see the Copper Reactivity section above before proceeding.
To further boost regeneration, anti-aging, and hair/skin optimization:
- Epithalon – For telomere repair, DNA integrity, and longevity
- CJC-1295 + Ipamorelin – To stimulate collagen, tissue recovery, and increase GH output
- Glutathione – For skin brightening, antioxidant protection, and detox support
- Snap-8 or Argireline – To layer on wrinkle reduction through topical use
- AOD-9604 – To help reduce stubborn fat while preserving skin elasticity during recomposition
- GHK-Cu Topical Cream – For localized skin enhancement (stacked with internal GLOW injections)
PubMed-linked citations for verification. Many studies are animal/in-vitro.
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520
- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. PMID: 26236730
- The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Oxid Med Cell Longev. 2012;2012:324832. PMID: 22666519
- The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-9. PMID: 17703734
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-80. PMID: 21030672
- Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-8. PMID: 10469335
Research Use Only. All information on this page is for educational purposes only and is not medical advice. PepSherpa does not sell peptides. Consult a licensed healthcare provider before making any health decisions. Many of the studies cited are preclinical (animal/in-vitro).
